White House Watch

Biden Admin Recommends Weeding Out Federal Marijuana Restrictions

A top official at the Department of Health and Human Services (HHS) recommended on Tuesday that the federal government ease its restrictions for marijuana, Bloomberg reported.

Dr. Rachel Levine, the assistant secretary of health for HHS, wrote a letter to the Drug Enforcement Agency (DEA) recommending that the government reclassify marijuana from a Schedule 1 drug to a Schedule 3 drug under the Controlled Substances Act to be considered as safe as drugs like testosterone and ketamine, according to Politico. Schedule 1 drugs include substances such as heroin and are considered extremely dangerous and addictive, while Schedule 3 drugs are considered only mildly addictive and can be acquired over the counter with a prescription, Bloomberg reported.

“Cannabis should have never been scheduled alongside heroin and placed at the center of our nation’s drug war,” said Edward Conklin, the executive director of the US Cannabis Council, according to Bloomberg. “Thankfully that era is coming to a close and is being replaced by a modern and scientific approach to regulating this plant.”

The HHS provided its recommendations on marijuana scheduling after receiving a directive requesting review of the drug from President Joe Biden, according to a DEA statement to the Daily Caller News Foundation. The department conducted a scientific and medical review of the drug before it submitted its findings in a letter to the DEA.

While rescheduling marijuana would decrease the penalties associated with illegal possession, the measure would not decriminalize the drug at the federal level, Politico reported.

The District of Columbia and 23 states allow for recreational use of marijuana, and 38 states as well as D.C. have legalized marijuana for medical use, USA Today reported.

“The only way to fully resolve the myriad of issues stemming from the federal conflict with state law is to remove cannabis from the Controlled Substances Act and regulate the product in a manner similar to alcohol,” Aaron Smith, the CEO of the National Cannabis Industry Association, said in a statement to Bloomberg.

The HHS did not immediately respond to the DCNF’s request for comment.

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact licensing@dailycallernewsfoundation.org

Lillian Tweten

Share
Published by
Lillian Tweten

Recent Posts

Trump DOJ Prepares Investigation Into Soros Organizations And It’s Quickly Leaked To Liberal Media

Several U.S. attorneys’ offices received instructions to draft plans for investigating billionaire George Soros’ Open…

22 hours ago

It’s No Joke, But Joy Reid Is

“I will confess to you, Joy. I do not have all the answers,” said Kamala…

22 hours ago

Officer Reportedly Thwarted Alleged Charlie Kirk Assassin’s Plans To Retrieve Rifle

A police officer reportedly encountered Tyler Robinson, the alleged assassin of Turning Point USA founder…

22 hours ago

Ditching Chuck Schumer Seems To Be Common Thread Among Many Democrats Running For Senate

Democratic U.S. Senate candidates running in several key races across the country are publicly distancing…

23 hours ago

Thorough Investigation Of Radical Left Is Warranted

With the assassination of beloved conservative icon Charlie Kirk, what’s been taking place in America…

23 hours ago

Trump’s Push To Rein In Drug Cost Manipulation Is Sorely Needed

With good reason, the Trump administration is prioritizing the reduction of drug prices, aiming to…

1 day ago